Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 491 | 66 | 101 | 32 | 3,281 |
| Operating Income | -491 | -66 | -101 | -32 | -3,281 |
| Interest Expense | 231 | 208 | 204 | 202 | 206 |
| Other Income | -392 | 484 | -59 | -421 | 115 |
| Pre-tax Income | -1,114 | 210 | -364 | -655 | -3,372 |
| Net Income Continuous | -1,114 | 210 | -364 | -655 | -3,372 |
| Minority Interests | -67 | -67 | -66 | -54 | -67 |
| Net Income | $-1,047 | $278 | $-299 | $-601 | $-3,305 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | N/A | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | N/A | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-437 | $-24 | $-62 | $-26 | $-66 |